A5089070790- HIV, Drug Use, Sexual Risk
- HIV/AIDS Research and Interventions
- Sex work and related issues
- Adolescent Sexual and Reproductive Health
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Opioid Use Disorder Treatment
- Vaccine Coverage and Hesitancy
- Hepatitis C virus research
- Substance Abuse Treatment and Outcomes
- COVID-19 and Mental Health
- Attachment and Relationship Dynamics
- Head and Neck Cancer Studies
- Mental Health and Patient Involvement
- Digital Mental Health Interventions
- Global Cancer Incidence and Screening
- Delphi Technique in Research
- Healthcare professionals’ stress and burnout
- Mental Health via Writing
- Cannabis and Cannabinoid Research
- Genital Health and Disease
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Mental Health Research Topics
- Oral Health Pathology and Treatment
- Geriatric Care and Nursing Homes
Merck & Co., Inc., Rahway, NJ, USA (United States)
2023-2025
Thomas Jefferson University
2022-2023
Johns Hopkins Medicine
2020-2022
Johns Hopkins University
2020-2022
University of Baltimore
2022
Drexel University
2017-2021
Columbia University
2015
To guide future preexposure prophylaxis (PrEP) implementation for women who inject drugs (WWID), a population increasingly represented in new HIV cases the United States, we present results from demonstration project integrated within syringe services program (SSP) Philadelphia, PA.WWID ≥18 years were educated about and offered 24 weeks of daily PrEP. Participants completed surveys clinical assessments at baseline 1, 3, 12, 24. We used descriptive statistics to estimate...
Importance In the US, oropharyngeal cancer, predominantly caused by high-risk (HR) human papillomavirus (HPV) infection, is most frequent HPV-associated surpassing cervical cancer. However, little known about oral HPV prevalence and genotype distribution in general population. Objective To assess factors associated with HR low-risk infection a US Design, Setting, Participants PROGRESS (Prevalence of Oral Infection, Global Assessment) was cross-sectional observational study conducted between...
In 2015, approximately 50,000 new HIV infections occurred in the United States, 2,400 of which were attributable to injection drug use. Preexposure prophylaxis (PrEP) has potential curb acquisition; however, uptake remains low among persons who inject drugs (PWID). The purpose study is describe PrEP eligibility, willingness use PrEP, and ability access PWID recruited from a pilot program that paired screening treatment sexually transmitted with mobile syringe exchange (SEP) services.Between...
The Health Belief Model has been useful for studying uptake of HIV prevention behaviors and had limited application to understanding utilization pre-exposure prophylaxis (PrEP), a biomedical strategy reduce acquisition. We recruited 90 persons undergoing screening educated them about PrEP. followed up with 35 participants approximately 3 weeks later quantitatively assessed PrEP uptake. No participant initiated conducted in-depth interviews 15 explore situational factors impacting this...
Hepatitis C virus (HCV) infection has increased among persons who inject drugs (PWID) in the United States with disproportionate burden rural areas. We use Risk Environment framework to explore potential economic, physical, social, and political determinants of hepatitis southern Illinois. Nineteen in-depth semi-structured interviews were conducted PWID from August 2019 through February 2020 (i.e., pre-COVID-19 pandemic) four key informants professionally worked PWID. Interviews recorded,...
Objectives Routine human papillomavirus (HPV) vaccination has been recommended in the United States since 2006 but rates remain suboptimal. State-based studies suggest that initiation late childhood at ages 9 to 10 years compared with early adolescent of 11 12 improves series completion. No study national scope explored initiation-HPV completion relationship. This addresses this knowledge gap and explores whether might improve by increasing time target age (time pathway) or moving an earlier...
Background: While studies have documented both the feasibility and acceptability of using ecological momentary assessment (EMA) to study drug use, there is little empirical research assessing participants' perceptions utilizing this technology-driven approach. Methods: Participants were English-speaking persons ≥18 years old who reported injection use sequential (e.g., alcohol followed by opioid use) or simultaneous (i.e., injecting heroin cocaine in one shot) polydrug within 30 days...
A qualitative egocentric social network approach was taken to explore motivations for pre-exposure prophylaxis (PrEP)-related communication between women who inject drugs and members. Eligible participants were HIV-negative, 18 years or older, participating in a PrEP demonstration project Philadelphia, PA, USA. The study employed content analysis of in-depth interviews identify themes related contextual relational factors impacting within networks. Participants ( n = 20) named on average...
Background: Overdose is a leading cause of morbidity and mortality among people who inject drugs. Illicitly manufactured fentanyl now major driver opioid overdose deaths. Methods: Semi-structured interviews were conducted with 23 participants (19 persons drugs 4 service providers) from rural southern Illinois. Data analyzed using constant comparison theoretical sampling methods. Results: Participants concerned about the growing presence in both opioids stimulants, many disclosed experiences....
Background Research surrounding attitudes and intentions concerning pre-exposure prophylaxis (PrEP) among at-risk heterosexuals, women ethnic racial minorities is needed to inform programs scale this effective HIV prevention intervention these populations. Methods:The study sample includes 192 HIV-negative heterosexuals recruited from testing sites operating in high prevalence neighbourhoods a mid-Atlantic city. Participants received brief educational sessions on PrEP completed...
Objective: Despite the efficacy of pre-exposure prophylaxis (PrEP) in reducing risk HIV infection, uptake remains low among many who are most vulnerable to HIV, such as Black and Latinx women. Interventions that target social networks encourage at-risk women initiate PrEP underused. Design: This study used an egocentric network design sampled Black/African American at well people from their (N = 211) a small, western city. Methods: Multivariable generalized linear mixed effects regression...
Some women who inject drugs (WWID) would benefit from pre-exposure prophylaxis (PrEP), yet there are few studies of issues related to uptake in real-world settings. In this study, participants (n = 95) were offered PrEP and responded items measuring PrEP-related attitudes, norms, perceived behavioral control based on the Theory Planned Behavior. We tested associations with intention initiate uptake. Most WWID (88%) intended 78% accepted a prescription. Compared did not express intentions,...
Drug overdose remains a major crisis in the United States. Expanding substance use disorder (SUD) treatment and recovery support services is critical for reducing risk during disasters such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) pandemic. We evaluated outcomes of an innovative multicomponent service, inclusive medications SUD, peer support, colocated outpatient infectious disease clinic Baltimore City. Our goal was to examine whether SUD program can patients...
The burden of human papillomavirus (HPV) and HPV-related cancers genital warts is increasing in developing countries, including Indonesia. objective this study was to qualitatively explore the humanistic economic these diseases patients In 2021, in-depth interviews focus groups were conducted with (N = 18) healthcare professionals (HCPs; N 10) specialised treating patients. Interviews explored physical, mental, social, diseases. Patients emphasised psychological social diseases, which...